or Try an Advanced Search...

    Technical Analysis for ACET - Adicet Bio, Inc.

    Grade Last Price % Change Price Change
    F 0.97 -6.11% -0.06
    ACET closed down 6.11 percent on Wednesday, November 20, 2024, on 2.11 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical ACET trend table...
    Date Alert Name Type % Chg
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Stochastic Buy Signal Bullish -6.11%
    Lower Bollinger Band Walk Weakness -6.11%
    Wide Bands Range Expansion -6.11%
    Gapped Up Strength -6.11%
    Oversold Stochastic Weakness -6.11%
    NR7 Range Contraction -0.08%
    Lower Bollinger Band Walk Weakness -0.08%
    Inside Day Range Contraction -0.08%
    Older End-of-Day Signals for ACET ...

       Recent Intraday Alerts

    Alert Time
    Lower Bollinger Band Support about 18 hours ago
    60 Minute Opening Range Breakdown about 21 hours ago
    Down 5% about 21 hours ago
    2x Volume Pace about 22 hours ago
    1.5x Volume Pace about 22 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ACET Chart by TradingView
    Basic chart:

    Profile

    Adicet Bio, Inc. is a biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer and other diseases. Adicet is advancing a pipeline of “off-the-shelf” gamma delta T cells, engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune response, and improve persistence for durable activity in patients.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Cancer Clinical Medicine Disease Immune System Antibodies Cancer Immunotherapy Chimeric Antigen Receptor T Cell Therapies For Cancer T Cell Chimeric Antigen Receptor Adoptive Cell Transfer Antigen Immune Response

    Is ACET a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 18 Adicet Opens Enrollment for ADI-270 Phase 1 Clinical Trial in Metastatic/Advanced Clear Cell Renal Cell Carcinoma
    Nov 18 Adicet Bio Announces First Lupus Nephritis Patient Dosed in Phase 1 Clinical Trial of ADI-001 in Autoimmune Diseases
    Nov 18 Is Adicet Bio (NASDAQ:ACET) In A Good Position To Deliver On Growth Plans?
    Nov 16 Adicet Bio Presents Clinical Biomarker Data for Off-the-Shelf CAR T Cell Therapy in an Oral Session at the American College of Rheumatology (ACR) Convergence 2024
    Nov 7 Adicet Bio GAAP EPS of -$0.34 in-line
    Nov 6 Adicet Reports Third Quarter 2024 Financial Results and Provides Business Updates
    Nov 5 Adicet Bio to Present at the American College of Rheumatology (ACR) Convergence 2024
    Oct 17 Adicet Bio Advances FDA-Approved Autoimmune Therapy Trials
    Oct 16 Adicet Bio gets FDA clearance of IND amendment for stiff person syndrome treatment
    Oct 16 Adicet Bio Announces FDA Clearance of IND Amendment to Evaluate ADI-001 in Idiopathic Inflammatory Myopathy and Stiff Person Syndrome
    See more ACET news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.7699
    52 Week Low 0.93
    Average Volume 490,201
    200-Day Moving Average 1.67
    50-Day Moving Average 1.36
    20-Day Moving Average 1.23
    10-Day Moving Average 1.12
    Average True Range 0.10
    RSI (14) 28.06
    ADX 23.8
    +DI 13.79
    -DI 30.30
    Chandelier Exit (Long, 3 ATRs) 1.25
    Chandelier Exit (Short, 3 ATRs) 1.22
    Upper Bollinger Bands 1.54
    Lower Bollinger Band 0.92
    Percent B (%b) 0.08
    BandWidth 50.65
    MACD Line -0.11
    MACD Signal Line -0.08
    MACD Histogram -0.0311
    Fundamentals Value
    Market Cap 79.35 Million
    Num Shares 82.1 Million
    EPS -3.35
    Price-to-Earnings (P/E) Ratio -0.29
    Price-to-Sales 14.00
    Price-to-Book 1.38
    PEG Ratio 0.82
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 1.14
    Resistance 3 (R3) 1.15 1.11 1.11
    Resistance 2 (R2) 1.11 1.06 1.10 1.10
    Resistance 1 (R1) 1.04 1.03 1.01 1.03 1.09
    Pivot Point 0.99 0.99 0.98 0.98 0.99
    Support 1 (S1) 0.92 0.95 0.90 0.91 0.84
    Support 2 (S2) 0.87 0.92 0.87 0.83
    Support 3 (S3) 0.80 0.87 0.82
    Support 4 (S4) 0.79